June 28, 2016 – FDA advisory committee recommends approval of Jardiance for cardiovascular indications.
Jun 2016 – FDA advisory committee recommendation
Announcement Date: June 28, 2016
June 28, 2016 – FDA advisory committee recommends approval of Jardiance for cardiovascular indications.